TY - JOUR AU - Mughal, T. I. AU - Radich, J. P. AU - Deininger, M. W. PY - 2016 DA - 2016// TI - Chronic myeloid leukemia: reminiscences and dreams JO - Haematologica VL - 101 ID - Mughal2016 ER - TY - JOUR AU - Hehlmann, R. AU - Hochhaus, A. AU - Baccarani, M. PY - 2007 DA - 2007// TI - Chronic myeloid leukaemia JO - The Lancet VL - 370 ID - Hehlmann2007 ER - TY - JOUR AU - Mendizabal, A. M. AU - Younes, N. AU - Levine, P. H. PY - 2016 DA - 2016// TI - Geographic and income variations in age at diagnosis and incidence of chronic myeloid leukemia JO - Int J Hematol VL - 103 ID - Mendizabal2016 ER - TY - JOUR AU - Barnes, D. J. AU - Melo, J. V. PY - 2002 DA - 2002// TI - Cytogenetic and molecular genetic aspects of chronic myeloid leukaemia JO - Acta Haematol VL - 108 ID - Barnes2002 ER - TY - JOUR AU - Stone, R. M. PY - 2004 DA - 2004// TI - Optimizing treatment of chronic myeloid leukemia: a rational approach JO - Oncologist VL - 9 ID - Stone2004 ER - TY - JOUR AU - Shanmuganathan, N. AU - Hiwase, D. K. AU - Ross, D. M. PY - 2017 DA - 2017// TI - Treatment of chronic myeloid leukemia: assessing risk, monitoring response, and optimizing outcome JO - Leuk Lymphoma VL - 58 ID - Shanmuganathan2017 ER - TY - JOUR AU - Bower, H. AU - Björkholm, M. AU - Dickman, P. W. PY - 2016 DA - 2016// TI - Life expectancy of patients with chronic Myeloid Leukemia approaches the life expectancy of the general population JO - J Clin Oncol VL - 34 ID - Bower2016 ER - TY - JOUR AU - Hochhaus, A. AU - Baccarani, M. AU - Silver, R. T. PY - 2020 DA - 2020// TI - European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia JO - Leukemia VL - 34 ID - Hochhaus2020 ER - TY - JOUR AU - Chihara, D. AU - Ito, H. AU - Matsuda, T. PY - 2012 DA - 2012// TI - Decreasing trend in mortality of chronic myelogenous leukemia patients after introduction of imatinib in Japan and the U.S JO - Oncologist. VL - 17 ID - Chihara2012 ER - TY - JOUR AU - Delord, M. AU - Foulon, S. AU - Cayuela, J. M. PY - 2018 DA - 2018// TI - The rising prevalence of chronic myeloid leukemia in France JO - Leuk Res VL - 69 ID - Delord2018 ER - TY - JOUR AU - Sasaki, K. AU - Strom, S. S. AU - O'Brien, S. PY - 2015 DA - 2015// TI - Relative survival in patients with chronic-phase chronic myeloid leukaemia in the tyrosine-kinase inhibitor era: analysis of patient data from six prospective clinical trials JO - Lancet Haematol VL - 2 ID - Sasaki2015 ER - TY - JOUR AU - Rodriguez-Abreu, D. AU - Bordoni, A. AU - Zucca, E. PY - 2007 DA - 2007// TI - Epidemiology of hematological malignancies JO - Ann Oncol VL - 18 ID - Rodriguez-Abreu2007 ER - TY - JOUR AU - Lin, L. AU - Yan, L. AU - Liu, Y. PY - 2019 DA - 2019// TI - Incidence and death in 29 cancer groups in 2017 and trend analysis from 1990 to 2017 from the Global Burden of Disease Study JO - J Hematol Oncol VL - 12 ID - Lin2019 ER - TY - STD TI - GBD 2017 DALYs and HALE Collaborators Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018; 392: 1859–1922. ID - ref14 ER - TY - STD TI - GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018; 392: 1789–1858. ID - ref15 ER - TY - STD TI - GBD 2017 Risk Factor Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018; 392: 1923–1994. ID - ref16 ER - TY - JOUR AU - Fitzmaurice, C. AU - Allen, C. AU - Barber, R. M. PY - 2017 DA - 2017// TI - Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study JO - JAMA Oncol VL - 3 ID - Fitzmaurice2017 ER - TY - JOUR AU - Thielen, N. AU - Visser, O. AU - Ossenkoppele, G. AU - Janssen, J. PY - 2016 DA - 2016// TI - Chronic myeloid leukemia in the Netherlands: a population-based study on incidence, treatment, and survival in 3585 patients from 1989 to 2012 JO - Eur J Haematol VL - 97 ID - Thielen2016 ER - TY - JOUR AU - Gomez-de-León, A. AU - Gómez-Almaguer, D. AU - Ruiz-Delgado, G. J. AU - Ruiz-Arguelles, G. J. PY - 2017 DA - 2017// TI - Insights into the management of chronic myeloid leukemia in resource-poor settings: a Mexican perspective JO - Expert Rev Hematol VL - 10 ID - Gomez-de-León2017 ER - TY - JOUR AU - Kurtovic-Kozaric, A. AU - Hasic, A. AU - Radich, J. P. PY - 2016 DA - 2016// TI - The reality of cancer treatment in a developing country: the effects of delayed TKI treatment on survival, cytogenetic and molecular responses in chronic myeloid leukaemia patients JO - Br J Haematol VL - 172 ID - Kurtovic-Kozaric2016 ER - TY - JOUR AU - Pasquini, M. C. PY - 2012 DA - 2012// TI - Hematopoietic cell transplantation for chronic myeloid leukemia in developing countries: perspectives from Latin America in the post-tyrosine kinase inhibitor era JO - Hematology VL - 17 ID - Pasquini2012 ER - TY - JOUR AU - Gómez-Almaguer, D. AU - Cantú-Rodríguez, O. G. AU - Gutiérrez-Aguirre, C. H. AU - Ruiz-Argüelles, G. J. PY - 2016 DA - 2016// TI - The treatment of CML at an environment with limited resources JO - Hematology VL - 21 ID - Gómez-Almaguer2016 ER - TY - JOUR AU - Cortes, J. AU - Rea, D. AU - Lipton, J. H. PY - 2019 DA - 2019// TI - Treatment-free remission with first- and second-generation tyrosine kinase inhibitors JO - Am J Hematol VL - 94 ID - Cortes2019 ER - TY - JOUR AU - Ross, D. M. AU - Hughes, T. P. PY - 2020 DA - 2020// TI - Treatment-free remission in patients with chronic myeloid leukaemia JO - Nat Rev Clin Oncol. VL - 11 ID - Ross2020 ER - TY - JOUR AU - Mahon, F. X. AU - Réa, D. AU - Guilhot, J. PY - 2010 DA - 2010// TI - Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial JO - Lancet Oncol VL - 11 ID - Mahon2010 ER - TY - JOUR AU - Campiotti, L. AU - Suter, M. B. AU - Guasti, L. PY - 2017 DA - 2017// TI - Imatinib discontinuation in chronic myeloid leukaemia patients with undetectable BCR-ABL transcript level: a systematic review and a meta-analysis JO - Eur J Cancer VL - 77 ID - Campiotti2017 ER - TY - JOUR AU - Saussele, S. AU - Richter, J. AU - Guilhot, J. PY - 2018 DA - 2018// TI - Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial JO - Lancet Oncol VL - 19 ID - Saussele2018 ER - TY - JOUR AU - Flynn, K. E. AU - Atallah, E. PY - 2016 DA - 2016// TI - Quality of life and long-term therapy in patients with chronic Myeloid Leukemia JO - Curr Hematol Malig Rep VL - 11 ID - Flynn2016 ER - TY - JOUR AU - Malhotra, H. AU - Radich, J. AU - Garcia-Gonzalez, P. PY - 2019 DA - 2019// TI - Meeting the needs of CML patients in resource-poor countries JO - Hematology Am Soc Hematol Educ Program VL - 2019 ID - Malhotra2019 ER - TY - JOUR AU - Lee, S. J. PY - 2000 DA - 2000// TI - Chronic myelogenous leukaemia JO - Br J Haematol VL - 111 ID - Lee2000 ER - TY - JOUR AU - Haan, G. AU - Lazare, S. S. PY - 2018 DA - 2018// TI - Aging of hematopoietic stem cells JO - Blood VL - 131 ID - Haan2018 ER - TY - JOUR AU - Verovskaya, E. V. AU - Dellorusso, P. V. AU - Passegué, E. PY - 2019 DA - 2019// TI - Losing sense of self and surroundings: hematopoietic stem cell aging and Leukemic transformation JO - Trends Mol Med VL - 25 ID - Verovskaya2019 ER - TY - JOUR AU - Kaiser, A. AU - Schmidt, M. AU - Huber, O. PY - 2020 DA - 2020// TI - SIRT7: an influence factor in healthy aging and the development of age-dependent myeloid stem-cell disorders JO - Leukemia VL - 34 ID - Kaiser2020 ER - TY - JOUR AU - Radich, J. P. AU - Deininger, M. AU - Abboud, C. N. PY - 2018 DA - 2018// TI - Chronic Myeloid Leukemia, Version 12019, NCCN clinical practice guidelines in oncology JO - J Natl Compr Canc Netw. VL - 16 ID - Radich2018 ER - TY - JOUR AU - Berger, U. AU - Maywald, O. AU - Pfirrmann, M. PY - 2005 DA - 2005// TI - Gender aspects in chronic myeloid leukemia: long-term results from randomized studies JO - Leukemia VL - 19 ID - Berger2005 ER - TY - JOUR AU - Höglund, M. AU - Sandin, F. AU - Simonsson, B. PY - 2015 DA - 2015// TI - Epidemiology of chronic myeloid leukaemia: an update JO - Ann Hematol VL - 94 ID - Höglund2015 ER - TY - JOUR AU - Micheli, A. AU - Mariotto, A. AU - Giorgi Rossi, A. PY - 1998 DA - 1998// TI - The prognostic role of gender in survival of adult cancer patients EUROCARE Working Group JO - Eur J Cancer VL - 34 ID - Micheli1998 ER - TY - JOUR AU - Shaw, H. M. AU - Milton, G. W. AU - Farago, G. AU - McCarthy, W. H. PY - 1978 DA - 1978// TI - Endocrine influences on survival from malignant melanoma JO - Cancer VL - 42 ID - Shaw1978 ER - TY - JOUR AU - Waldron, I. PY - 1983 DA - 1983// TI - Sex differences in illness incidence, prognosis and mortality: issues and evidence JO - Soc Sci Med VL - 17 ID - Waldron1983 ER - TY - JOUR AU - Torre, L. A. AU - Islami, F. AU - Siegel, R. L. PY - 2017 DA - 2017// TI - Global Cancer in Women: Burden and Trends JO - Cancer Epidemiol Biomarkers Prev VL - 26 ID - Torre2017 ER - TY - JOUR AU - Islami, F. AU - Torre, L. A. AU - Drope, J. M. PY - 2017 DA - 2017// TI - Global cancer in women: cancer control priorities JO - Cancer Epidemiol Biomarkers Prev VL - 26 ID - Islami2017 ER - TY - JOUR AU - Lauseker, M. AU - Hasford, J. AU - Saussele, S. PY - 2017 DA - 2017// TI - Smokers with chronic myeloid leukemia are at a higher risk of disease progression and premature death JO - Cancer VL - 123 ID - Lauseker2017 ER - TY - JOUR AU - Bilano, V. AU - Gilmour, S. AU - Moffiet, T. PY - 2015 DA - 2015// TI - Global trends and projections for tobacco use, 1990–2025: an analysis of smoking indicators from the WHO comprehensive information systems for tobacco control JO - Lancet VL - 385 ID - Bilano2015 ER - TY - JOUR AU - Jha, P. AU - Peto, R. PY - 2014 DA - 2014// TI - Global effects of smoking, of quitting, and of taxing tobacco JO - N Engl J Med VL - 370 ID - Jha2014 ER - TY - JOUR AU - Chaloupka, F. J. AU - Straif, K. AU - Leon, M. E. PY - 2011 DA - 2011// TI - Effectiveness of tax and price policies in tobacco control JO - Tob Control VL - 20 ID - Chaloupka2011 ER - TY - JOUR AU - Levy, D. T. AU - Meza, R. AU - Zhang, Y. AU - Holford, T. R. PY - 2016 DA - 2016// TI - Gauging the Effect of U.S. Tobacco control policies from 1965 through 2014 using SimSmoke JO - Am J Prev Med VL - 50 ID - Levy2016 ER - TY - JOUR AU - Castillo, J. J. AU - Reagan, J. L. AU - Ingham, R. R. PY - 2012 DA - 2012// TI - Obesity but not overweight increases the incidence and mortality of leukemia in adults: a meta-analysis of prospective cohort studies JO - Leuk Res VL - 36 ID - Castillo2012 ER - TY - JOUR AU - Calle, E. E. AU - Rodriguez, C. AU - Walker-Thurmond, K. AU - Thun, M. J. PY - 2003 DA - 2003// TI - Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults JO - N Engl J Med. VL - 348 ID - Calle2003 ER - TY - JOUR AU - Rokholm, B. AU - Baker, J. L. AU - Sørensen, T. I. PY - 2010 DA - 2010// TI - The levelling off of the obesity epidemic since the year 1999–a review of evidence and perspectives JO - Obes Rev VL - 11 ID - Rokholm2010 ER - TY - JOUR AU - Chooi, Y. C. AU - Ding, C. AU - Magkos, F. PY - 2019 DA - 2019// TI - The epidemiology of obesity JO - Metabolism VL - 92 ID - Chooi2019 ER - TY - JOUR AU - Popkin, B. M. AU - Adair, L. S. AU - Ng, S. W. PY - 2012 DA - 2012// TI - Global nutrition transition and the pandemic of obesity in developing countries JO - Nutr Rev VL - 70 ID - Popkin2012 ER - TY - JOUR AU - Yi, M. AU - Li, A. AU - Zhou, L. PY - 2020 DA - 2020// TI - The global burden and attributable risk factor analysis of acute myeloid leukemia in 195 countries and territories from 1990 to 2017: estimates based on the global burden of disease study 2017 JO - J Hematol Oncol VL - 13 ID - Yi2020 ER -